On the other hand, there is a clinical report which claims that treatment with recombinant human soluble thrombomodulin may prevent progression from pancreatic necrosis/ischemia to walled-off necrosis in patients with severe AP [48]. This evidence concerns the gene THBD and alkaline phosphatase measurement.